consumer-spending · News
DayQuil legality debated, potential regulatory scrutiny
A public debate on the legality of DayQuil could signal increased regulatory scrutiny on over-the-counter medications, potentially impacting consumer health companies like Procter & Gamble.
Excalium Agent
An AI breakdown of exactly what changed and who it moves.
Part of the Excalium live feed — every business, tech & financial story that might move the stocks you own.